Capecitabine

SIAL/Y0001642 - European Pharmacopoeia (EP) Reference Standard

Synonym: 5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine; Ro-9-1978

CAS Number: 154361-50-9
Empirical Formula (Hill Notation): C₁₅H₂₂FN₃O₆
Molecular Weight: 359.35
MDL Number: MFCD00930626
Linear Formula: C₁₅H₂₂FN₃O₆
Product Type: Chemical

Catalog Number	PKG Qty.	Price	Quantity


45-Y0001642	150 mg	$156.00 1/EAAdd To Favorites		Add To Favorites

API family	capecitabine
application(s)	pharmaceutical (small molecule)
format	neat
grade	pharmaceutical primary standard
InChI	1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
InChI key	GAGWJHPBXLXJQN-UORFTKCHSA-N
manufacturer/tradename	EDQM
SMILES string	O[C@H]1[C@@H](O)[C@H](N2C(N=C(NC(OCCCCC)=O)C(F)=C2)=O)O[C@@H]1C
storage temp.	2-8°C

Application:	Capecitabine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Biochem/physiol Actions:	Capecitabine is an anti-cancer drug, a prodrug of doxifluridine, metabolized to 5-fluorouracil at the tumor site. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5′-Deoxy-5-fluorocytidine (5′-DFCR) and 5′-Deoxy-5-fluorouridine (5′-DFUR), to form 5-fluorouracil.
General description:	This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia .
Other Notes:	Sales restrictions may apply.
Packaging:	The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue .